Tri-Institutional MD-PhD Program

Alumni Publications

2006

Draper MW. 2006. An update on raloxifene.. Int J Gynecol Cancer. 16 Suppl 2:502-3.

Martin DL, D Weatherly B, Laucella SA, Cabinian MA, Crim MT, Sullivan S, Heiges M, Craven SH, Rosenberg CS, Collins MH et al.. 2006. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes.. PLoS Pathog. 2(8):e77.

2005

Onwueme KC, Vos CJ, Zurita J, Ferreras JA, Quadri LEN. 2005. The dimycocerosate ester polyketide virulence factors of mycobacteria.. Prog Lipid Res. 44(5):259-302.

Wolf E, Schneider MR, Zhou R, Fisch TM, Herbach N, Dahlhoff M, Wanke R, Hoeflich A. 2005. Functional consequences of IGFBP excess-lessons from transgenic mice.. Pediatr Nephrol. 20(3):269-78.

Halaas JL, Moskowitz CH, Horwitz S, Portlock C, Noy A, Straus D, O'Connor OA, Yahalom J, Zelenetz AD. 2005. R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy.. Leuk Lymphoma. 46(4):541-7.

Onwueme KC, Vos CJ, Zurita J, Soll CE, Quadri LEN. 2005. Identification of phthiodiolone ketoreductase, an enzyme required for production of mycobacterial diacyl phthiocerol virulence factors.. J Bacteriol. 187(14):4760-6.

Nonacs RM, Soares CN, Viguera AC, Pearson K, Poitras JR, Cohen LS. 2005. Bupropion SR for the treatment of postpartum depression: a pilot study.. Int J Neuropsychopharmacol. 8(3):445-9.

Brewer GJ, Askari FK. 2005. Wilson's disease: clinical management and therapy.. J Hepatol. 42 Suppl(1):S13-21.

Tsai JC, Kanner EM. 2005. Current and emerging medical therapies for glaucoma.. Expert Opin Emerg Drugs. 10(1):109-18.

2004

Amprey JL, Späth GF, Porcelli SA. 2004. Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani.. Infect Immun. 72(1):589-92.